IndraLab

Statements

KCNH2 activates LQT mutation. 1 / 1

| 1

reach

"In addition, 100nM AST was also added to the hiPSC-CMs carrying LQTS mutations, thus simulating invitro what happens to LQT mutation carriers treated with hERG blocking drugs (Kannankeril etal, 2010; Schwartz, 2015)."

27470144

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

KCNH2 activates LQT mutation. 1 / 1

INDRA sources:

Databases

Reading